JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MATTOCKS, A. M.
Right arrow Articles by HOLTAN, S. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MATTOCKS, A. M.
Right arrow Articles by HOLTAN, S. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 96, Issue 2, 114-118, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics


THE INHIBITION OF ACID PHOSPHATASE OF SHEEP BRAIN

ALBERT M. MATTOCKS 1 and SALLY D. HOLTAN 1

1 School of Pharmacy, Western Reserve University, Cleveland, Ohio

1. Structural similarity between certain drugs known to act on the nervous system and glycerophosphorylcholine suggested possible competitive action, and a number of these drugs were tested for their effect on the hydrolysis of betaglycerophosphate and phosphorylcholine by brain extracts at pH 5.0. Only one of the drugs tested (DFP) inhibited the enzyme system, and it was concluded that acid phosphatases are not the site of action of these substances.

2. Fluoride inhibited noncompetitively; sulfate, pyrophosphate, and DFP inhibited acid glycerophosphatase competitively, their Ki values being 7.52 x 10-4, 2.35 x 10-4, and 5.04 x 10-4, respectively.

Submitted on January 17, 1949







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.